Gary S. Gillheeney, the President and CEO of $ORGO ($ORGO), sold 55,615 shares of the company on 12-13-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.8%...
Gary S. Gillheeney, the President and CEO of $ORGO ($ORGO), sold 43,359 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.4%...
Gary S. Gillheeney, the President and CEO of $ORGO ($ORGO), sold 18,416 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.5%...
Organogenesis Holdings plans to expand with a new 122,000 sq. ft. biomanufacturing facility in Rhode Island.Quiver AI SummaryOrganogenesis Holdings Inc., a regenerative medicine company, announced plans...
Organogenesis praises CMS decision allowing Medicare coverage for skin substitutes treating diabetic and venous ulcers starting February 2025.Quiver AI SummaryOrganogenesis Holdings Inc. has praised the...
ORGO earnings call for the period ending September 30, 2024.